Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Morningside Venture Partners

Investor type Angel Group


Unlock datapoints

Portfolio analytics



News & Media

Add fund to favorites
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Looking for a perfect list of funds?

Get recommendations from our smart algorithm

Get the list
Total investments 35
Average round size
The average size of a deal this fund participated in
Portfolio companies 29
Rounds per year 8.75
Lead investments 5
Follow on index
How often the fund supports its portfolio startups at next rounds
Exits 6
Key employees 1
Stages of investment
Early Stage Venture

Areas of investment

  • Biotechnology
  • Health Care
  • Medical
  • Therapeutics
  • Pharmaceutical

Morningside Venture Partners appeared to be the VC, which was created in 1986. The main department of described VC is located in the Shanghai. The venture was found in Asia in China.

The typical case for the fund is to invest in rounds with 3-4 participants. Despite the Morningside Venture Partners, startups are often financed by Providence Investment Company Limited, Nesta Ventures, UK Innovation & Science Seed Fund. The meaningful sponsors for the fund in investment in the same round are Providence Investment Company Limited, Takeda Ventures, Nesta Ventures. In the next rounds fund is usually obtained by Providence Investment Company Limited, Temasek Holdings, Takeda Ventures.

This organization was formed by Ronnie Chan. The overall number of key employees were 1.

Among the most popular portfolio startups of the fund, we may highlight Xiaomi, ENYO Pharma, Milk and Eggs. Besides, a startup needs to be aged 6-10 years to get the investment from the fund. For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States. The fund has no exact preference in a number of founders of portfolio startups. If startup sums 3 or 4 of the founder, the chance for it to be financed is low.

This Morningside Venture Partners works on 12 percentage points less the average amount of lead investments comparing to the other organizations. The important activity for fund was in 2018. The fund is generally included in less than 2 deals every year. Speaking about the real fund results, this VC is 5 percentage points more often commits exit comparing to other organizations. The common things for fund are deals in the range of 10 - 50 millions dollars. The higher amount of exits for fund were in 2019. The typical startup value when the investment from Morningside Venture Partners is 10-50 millions dollars.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Morningside Venture Partners:
Typical Co-investors
Morningside Venture Partners is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Morningside Venture Partners:
1 Bose

Funds with similar focus

Funds from United States
Funds with similar focus located in United States:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
American-Value Fund -
Amtech California, San Francisco, United States
APAMAN Japan, Tokyo
Fullerton Financial Holdings Central Region, Singapore, Singapore
JC Management -
KSP investment fund -
KYMCO Capital China, Fujian, Taipei
Lagunita BioSciences LLC California, Menlo Park, United States
LEO Group China, Wenling, Zhejiang
Mantra Investment Partners -
Matsuo Sangyo Japan, Osaka, Osaka Prefecture
MIT Media Lab Cambridge, Massachusetts, United States
Neoteny 4 -
Sage Hill Partners, LLC -
University of Waterloo Canada, Ontario, Waterloo
Venturi Group Minnesota, Saint Paul, United States
Xiamen Fenghuang Huaji China, Fujian, Xiamen

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Otolith Labs

Consumer Electronics
Medical Device
$20M07 Sep 2022 Washington, District of Columbia, United States


Artificial Intelligence
Health Care
Health Diagnostics
Machine Learning
Medical Device
$30M22 Mar 2022 Oakland, California, United States


26 Jan 2022 Cambridge, England, United Kingdom


Health Care
Medical Device
$30M21 Jan 2022 Rochester, New York, United States


$43M03 Nov 2021 Boston, Massachusetts, United States

Exo Therapeutics

Health Care
$78M05 Oct 2021 Cambridge, Massachusetts, United States

Artificial Intelligence
Machine Learning
$30M08 Apr 2021 Boston, Massachusetts, United States

Tallac Therapeutics

Health Care
$62M01 Dec 2020 California, United States

Gracell Biotechnologies

Health Care
$100M28 Oct 2020 Gusu District, Jiangsu, China
Alyce Raises $30M in Series B Funding

– Alyce is a Boston, MA-based provider of a Personal Experience (PX) platform.
– Company raised $30m in Series B funding.
– The round was led by General Catalyst with participation from incumbent investors Manifest, Morningside, Boston Seed Capital, Golden Ventures, and Victress Capital.
– In conjunction with the funding, General Catalyst‘s Executive-in-Residence Lou Shipley joined Alyce’s board and Managing Partner Larry Bohn will become a board observer.
– The company intends to use the funds to accelerate growth through R&D, hiring, increased sales and customer support.


  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Morningside Venture Partners?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: